TARMED to TARDOC in Swiss outpatients — what’s changing?

TARDOC, coming into effect January 2026, replaces TARMED specifically for outpatient services. Switzerland has different tariff systems depending on the treatment setting: outpatient means patients don’t stay overnight in hospital, while inpatient means at least one night or a stay over 24 hours. The new system It’s designed to be simpler, more adaptable, and better reflect actual medical work and new technologies. It introduces flat-rate tariffs based on detailed, updated cost and service data, covering around 2,630 individual codes of specialties and procedure types.

What does it mean for patients? TARDOC aims to improve outpatient care in Switzerland by better valuing long, complex consultations—especially for chronic conditions—and supporting new tech like teleconsultations. This means more personalized, thorough care and easier access to modern treatments.

Good news: TARDOC is designed to be cost-neutral for mandatory health insurance, so it shouldn’t make premiums go up. The outpatient flat-rate system covers all services performed on a given day of surgery in a single lump sum. This includes all treatments that take place on the same day. Initial consultations and follow-up treatments on other days continue to be billed according to the individual service tariff.

What changes for insurance companies?  TARDOC means a fairer, more predictable reimbursement system. They can better manage their financial risks because tariffs now match the real effort and tech involved. It also reduces big differences between specialties that used to cause unexpected cost jumps, which helps keep premiums stable.

What does it mean for hospital clinics? TARDOC brings changes: some specialities might see their revenues drop, while others—especially those offering complex or time-consuming services—could get paid better. This will shift profitability between departments.

Under the old TARMED system, some expensive exams like MRI, CT scans, or treatments such as breast cancer radiotherapy weren’t reimbursed at rates covering the true costs of the technology and personnel. With TARDOC, these tariffs have been updated to more realistically reflect actual expenses, which should mean fairer compensation for these costly services. Clinics need to get ready by upgrading their billing and management software, training their staff, and running financial simulations to understand how the new tariffs will affect their income.

What about Pharmacies? Up until now, Swiss pharmacies got paid mainly for dispensing prescription meds under older agreements like LOA IV/1. But that system didn’t really keep up with how pharmacy work has changed or the extra services they now offer.

Starting January 1, 2026, LOA V and the new TARDOC tariff system will shake things up. Payments will better match the actual workload and quality of services. That means new stuff like machine blistering or mail-order pharmacies will finally be included. This change is good news: it makes pharmacy payments fairer and more aligned with real pharmaceutical care. It also helps keep healthcare costs under control for insurers and patients.

From a health economics angle, there’s a big push for tariffs to be updated dynamically, based on solid evidence that includes cost-effectiveness and value-based pricing. Faster approval and tariff inclusion of innovative digital health tools and medical devices can drive better health outcomes, save resources, and encourage innovation.

Reforming how health economic evidence is tied into TARDOC’s pricing and reimbursement is key to getting new technologies recognized and rewarded on time.

OTMA SA welcomes the Federal Council's decision to approve the additions to the global tariff system, consisting of TARDOC and outpatient packages, which will come into force on January 1, 2026. TARDOC was developed by the FMH in collaboration with curafutura and the UVG Medical Tariff Commission (MTK) and a first version was submitted to the Federal Council for approval in 2019.